Condition
Prostate Cancer Aggressiveness
Total Trials
4
Recruiting
1
Active
2
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 2 (1)
Trial Status
Completed1
Recruiting1
Active Not Recruiting1
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT04052048RecruitingPrimary
Active Surveillance SNEP Assay Registry Trial for Prostate Cancer
NCT03263650Phase 2Active Not RecruitingPrimary
Study of Olaparib Maintenance Following Cabazitaxel-Carbo in Men With AVPC
NCT05384002Completed
An AI Platform Integrating Imaging Data and Models, Supporting Precision Care Through Prostate Cancer's Continuum
NCT06662708Not ApplicableNot Yet Recruiting
Artificial Intelligence Models for Precision Prediction and Treatment of Prostate Cancer
Showing all 4 trials